Clinical Trials Directory

Trials / Sponsors / Eiger BioPharmaceuticals

Eiger BioPharmaceuticals

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
UnknownPhase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chroni
Hepatitis Delta Virus
Phase 32021-12-21
CompletedStudy of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Hepatitis Delta Virus
Phase 32018-12-01
CompletedSafety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Postbariatric Hypoglycemia
Phase 22018-03-19
TerminatedOpen-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Pulmonary Arterial Hypertension
Phase 22016-12-01
CompletedA Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Inf
Hepatitis D, Chronic
Phase 22016-10-19
CompletedUbenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)
Lymphedema
Phase 22016-06-01
CompletedA Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Pulmonary Arterial Hypertension
Phase 22016-04-01
CompletedTitrating-Dose of Lonafarnib in Combination With Ritonavir
Chronic Delta Hepatitis
Phase 22015-09-01
CompletedLonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)
Chronic Hepatitis D Infection
Phase 22014-12-01
CompletedLonafarnib With and Without Ritonavir in HDV (LOWR-1)
Chronic Hepatitis D Infection
Phase 22014-11-01
TerminatedProof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Hepatitis D
Phase 12011-01-01
CompletedSafety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Na
Hepatitis C
Phase 12009-07-01
Approved For MarketingLonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy
Progeria, HGPS
——
WithdrawnA Study of Lonafarnib With or Without Ritonavir in Patients With HDV
Chronic Delta Hepatitis
Phase 2—